Literature DB >> 2690015

Expression of tetanus toxin fragment C in E. coli: high level expression by removing rare codons.

A J Makoff1, M D Oxer, M A Romanos, N F Fairweather, S Ballantine.   

Abstract

Tetanus toxin fragment C had been previously expressed in Escherichia coli at 3-4% cell protein. The codon bias for tetanus toxin in Clostridium tetani is very different from that of highly expressed homologous genes in E. coli, resulting in the presence of many rare E. coli codons in the sequence encoding fragment C. We have replaced the coding sequence by sequence optimized for codon usage in E. coli, and show that the expression of fragment C is increased. Although the level of mRNA also increased this appeared to be a secondary consequence of more efficient translation. Complete sequence replacement increased expression to approximately 11-14% cell protein but only after the promoter strength had been improved.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2690015      PMCID: PMC335293          DOI: 10.1093/nar/17.24.10191

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  41 in total

1.  High level expression of chicken muscle adenylate kinase in Escherichia coli.

Authors:  Y Tanizawa; F Kishi; T Kaneko; A Nakazawa
Journal:  J Biochem       Date:  1987-05       Impact factor: 3.387

2.  Overproduction from a cellulase gene with a high guanosine-plus-cytosine content in Escherichia coli.

Authors:  G P O'Neill; D G Kilburn; R A Warren; R C Miller
Journal:  Appl Environ Microbiol       Date:  1986-10       Impact factor: 4.792

3.  Codon-defined ribosomal pausing in Escherichia coli detected by using the pyrE attenuator to probe the coupling between transcription and translation.

Authors:  F Bonekamp; H D Andersen; T Christensen; K F Jensen
Journal:  Nucleic Acids Res       Date:  1985-06-11       Impact factor: 16.971

4.  The pIC plasmid and phage vectors with versatile cloning sites for recombinant selection by insertional inactivation.

Authors:  J L Marsh; M Erfle; E J Wykes
Journal:  Gene       Date:  1984-12       Impact factor: 3.688

5.  Cloning and expression of cDNA for salmon growth hormone in Escherichia coli.

Authors:  S Sekine; T Mizukami; T Nishi; Y Kuwana; A Saito; M Sato; S Itoh; H Kawauchi
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

6.  High-level expression of human interferon gamma in Escherichia coli under control of the pL promoter of bacteriophage lambda.

Authors:  G Simons; E Remaut; B Allet; R Devos; W Fiers
Journal:  Gene       Date:  1984-04       Impact factor: 3.688

7.  Vectors bearing a hybrid trp-lac promoter useful for regulated expression of cloned genes in Escherichia coli.

Authors:  E Amann; J Brosius; M Ptashne
Journal:  Gene       Date:  1983-11       Impact factor: 3.688

Review 8.  Preferential codon usage in prokaryotic genes: the optimal codon-anticodon interaction energy and the selective codon usage in efficiently expressed genes.

Authors:  H Grosjean; W Fiers
Journal:  Gene       Date:  1982-06       Impact factor: 3.688

9.  Expression of p21 proteins in Escherichia coli and stereochemistry of the nucleotide-binding site.

Authors:  J Tucker; G Sczakiel; J Feuerstein; J John; R S Goody; A Wittinghofer
Journal:  EMBO J       Date:  1986-06       Impact factor: 11.598

10.  AIDS virus reverse transcriptase defined by high level expression in Escherichia coli.

Authors:  B Larder; D Purifoy; K Powell; G Darby
Journal:  EMBO J       Date:  1987-10       Impact factor: 11.598

View more
  38 in total

1.  Expression of tetanus toxin Fragment C in tobacco chloroplasts.

Authors:  John S Tregoning; Peter Nixon; Hiroshi Kuroda; Zora Svab; Simon Clare; Frances Bowe; Neil Fairweather; Jimmy Ytterberg; Klaas J van Wijk; Gordon Dougan; Pal Maliga
Journal:  Nucleic Acids Res       Date:  2003-02-15       Impact factor: 16.971

2.  Exogenous mRNA encoding tetanus or botulinum neurotoxins expressed in Aplysia neurons.

Authors:  S Mochida; B Poulain; U Eisel; T Binz; H Kurazono; H Niemann; L Tauc
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

3.  High level heterologous expression in E. coli using mutant forms of the lac promoter.

Authors:  A J Makoff; M D Oxer
Journal:  Nucleic Acids Res       Date:  1991-05-11       Impact factor: 16.971

4.  Synthesis of tetanus toxin fragment C in insect cells by use of a baculovirus expression system.

Authors:  I G Charles; B C Rodgers; A J Makoff; S N Chatfield; D E Slater; N F Fairweather
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

5.  Construction and expression of recombinant streptolysin-o and preevaluation of its use in immunoassays.

Authors:  Blanca Velázquez; Hugo Massaldi; Julio Battistoni; José A Chabalgoity
Journal:  Clin Diagn Lab Immunol       Date:  2005-05

6.  Codon usage in pathogenic Entamoeba histolytica.

Authors:  E Tannich; R D Horstmann
Journal:  J Mol Evol       Date:  1992-03       Impact factor: 2.395

7.  Highly immunogenic and protective recombinant vaccine candidate expressed in transgenic plants.

Authors:  Daniel Chargelegue; Pascal M W Drake; Patricia Obregon; Alessandra Prada; Neil Fairweather; Julian K-C Ma
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

8.  Efficacy of a potential trivalent vaccine based on Hc fragments of botulinum toxins A, B, and E produced in a cell-free expression system.

Authors:  R Zichel; A Mimran; A Keren; A Barnea; I Steinberger-Levy; D Marcus; A Turgeman; S Reuveny
Journal:  Clin Vaccine Immunol       Date:  2010-03-31

Review 9.  Properties and use of botulinum toxin and other microbial neurotoxins in medicine.

Authors:  E J Schantz; E A Johnson
Journal:  Microbiol Rev       Date:  1992-03

10.  Optimized clostridium-directed enzyme prodrug therapy improves the antitumor activity of the novel DNA cross-linking agent PR-104.

Authors:  Shie-Chau Liu; G-One Ahn; Mitomu Kioi; Mary-Jo Dorie; Adam V Patterson; J Martin Brown
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.